Tanvi Patel, vice president and general manager of Amazon Pharmacy, and her co-panelists at the recent Bullseye event, ...

With home health fraud growing more sophisticated through AI, post-pay audits are no longer enough. Payers must shift to ...

Small group insurers are proposing a median 14% premium increase for 2027, driven by rising healthcare costs. Small group insurers are proposing a median 14% increase in premiums for 2027, according ...

Jazz Pharmaceuticals, maker of the blockbuster epilepsy drug Epidiolex, is acquiring Actio Biosciences and its lead drug in ...

Hinge Health’s acquisition of Cylinder expands it into GI care, but experts differ on whether employers will favor ...

Latigo Biotherapeutics will apply the IPO proceeds toward a pipeline that includes a next-generation non-opioid pain drug ...

Last week, CMS issued more details on a new pathway it is establishing to speed up Medicare coverage for innovative medical devices. The Regulatory Alignment for Predictable and Immediate Device ...

One takeaway from this year’s surge of biotech IPO activity is that investors want to see at least some clinical data before a company makes its stock market debut. Braveheart Bio has mid-stage trial ...

The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to ...

The healthcare provider industry isn’t collapsing — but it is fragmenting, according to data from healthcare restructuring firm Gibbins Advisors. The firm published a report last week showing ...

A new healthcare-focused investment firm launched on Tuesday with support from Nueterra Capital. It’s seeking to help early-stage companies navigate the jump from product validation to true commercial ...

Odyssey Therapeutics continues the immunology journey of serial biotech entrepreneur Gary Glick, who is pursuing drugs that could offer advantages over many currently available medicines. The Odyssey ...